Detect

Guilford, United States Founded: 1996 • Age: 30 yrs
Diagnostics for womens health are transformed through innovative solutions.

About Detect

Detect is a company based in Guilford (United States) founded in 1996 by Spencer Glantz and Jonathan Rothberg. It operates as a HealthTech. Detect offers products and services including Vaginitis Diagnostic Platform and Sexual and Hormonal Health Solutions. Detect operates in a competitive market with competitors including Tachmed and AfimaCheck, among others.

  • Headquarter Guilford, United States
  • Founders Spencer Glantz, Jonathan Rothberg
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website detect.com
  • Social LinkedIn
Operational Areas

Products & Services of Detect

Detect offers a comprehensive portfolio of products and services, including Vaginitis Diagnostic Platform and Sexual and Hormonal Health Solutions.

Vaginitis Diagnostic Platform
Diagnostics

Accurate diagnostics for vaginitis are provided through innovation.

Sexual and Hormonal Health Solutions
Diagnostics

Solutions for sexual and hormonal health are being developed.

People of Detect

18 people are tracked at Detect (9 in leadership, 1 in board & advisors, 8 in team).

NameRoleGroup
Spencer Glantz
Co-Founder & Vice President Of Research And DevelopmentLeadership
Jonathan Rothberg
Co-FounderLeadership
Michael Bourgeault
Vice President FinanceLeadership
Anthony Bellofiore
Head of Device SoftwareLeadership
Tyson Grant
Vice President Of EngineeringLeadership
William Hansen
Director, Chemistry and Molecular InnovationLeadership
Thiago Krauss
Vice President of Supply ChainLeadership
Varsha Baichwal
Head Of Customer ExperienceLeadership
Barbara Feringa
Senior Vice President, Marketing & Market AccessLeadership
Hugo Barra
ChairmanBoard & advisors
Poonam Sharma
Senior Scientist ManagerTeam
David Kamber
Principle Scientist, Organic ChemistryTeam
Allison Bailey
Staff ScientistTeam
Roger Nani
Principal ScientistTeam
Koli Ndoni
Supply Chain ControllerTeam
Maylon Pedroso García
Senior Software DeveloperTeam
Adam Holtzberg
Recruiting & People AssociateTeam
Juan Vallejo
Front-End Lead Web and MobileTeam
Premium access

Complete people profiles for Detect

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Detect

Detect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tachmed and AfimaCheck, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tachmed.com2018Wilmslow, United Kingdom––
Offers digital devices for at-home health monitoring, diagnosis, and data sharing services.
afimacheck.com2021Toronto, Canada––
Developer of thermal reader technology for onsite drug testing applications
Premium access

Detailed competitors of Detect

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Detect

The website of Detect (detect.com) receives about 2.4K visits a month.

  • Monthly visits
    2.4K

    ▼ 24.6% vs previous month

Latest news on Detect

Premium access

Complete news archive for Detect

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Detect

10 companies that operate in the same segment as Detect (Infectious Diseases), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Clinical diagnostics and drug discovery for immune diseases are provided.
2009Seattle, Washington, United StatesUSD 419.15 MUSD 276.98 M619
Vaccines for infectious diseases are developed using cell-free protein synthesis.
2013Foster City, California, United StatesUSD 347 M–414
Portable PCR diagnostics for infectious diseases are developed.
2010San Jose, California, United StatesUSD 386.33 M––
Developing glucan synthase inhibitors for the treatment of fungal infections.
1999Jersey City, New Jersey, United StatesUSD 62.65 MUSD 20.6 M28
Sherlock Biosciences is focused on molecular diagnostics development.
2019Watertown, United StatesUSD 111 M–33
Provider of diagnostic solutions for systemic infections
2016San Francisco, California, United StatesUSD 191.47 M–54
Developer of novel protein-based therapeutics using machine learning and biological engineering
2018Somerville, Massachusetts, United StatesUSD 693 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Detect

Detect was founded in 1996.

Detect is headquartered in Guilford, United States. It is registered at Guilford, Connecticut, United States.

Womens health diagnostics are addressed by Detect through a molecular, multiplex platform. Solutions for conditions like vaginitis, sexual, and hormonal health are developed. Rapid, accurate, and easy-to-use testing is provided at the point of need. Clinicians and patients are empowered with reliable results and peace of mind. Innovation is driven by custom reagents, AI-enabled design, and compact devices. The focus is placed on underserved areas in womens healthcare.

Detect's top competitors include AfimaCheck and Tachmed.

Detect offers Vaginitis Diagnostic Platform and Sexual and Hormonal Health Solutions.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available